Wang Y - Search Results

1

Metabolic characteristics of [¹⁸F]fluoroboronotyrosine (FBY) PET in malignant brain tumors.

Kong Z, Li Z, Chen J, Liu S, Liu D, Li J, Li N, Ma W, Feng F, Wang Y, Yang Z, Liu Z. Kong Z, et al. Among authors: wang y. Nucl Med Biol. 2022 Mar-Apr;106-107:80-87. doi: 10.1016/j.nucmedbio.2022.01.002. Epub 2022 Jan 10. Nucl Med Biol. 2022. PMID: 35091195

2

Quantitative Features From CHO PET Distinguish the WHO Grades of Primary Diffuse Glioma.

Kong Z, Jiang C, Liu D, Chen W, Ma W, Cheng X, Wang Y. Kong Z, et al. Among authors: wang y. Clin Nucl Med. 2021 Feb 1;46(2):103-110. doi: 10.1097/RLU.0000000000003406. Clin Nucl Med. 2021. PMID: 33208625

3

Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.

Kong Z, Zhang Y, Liu D, Liu P, Shi Y, Wang Y, Zhao D, Cheng X, Wang Y, Ma W. Kong Z, et al. Among authors: wang y. Ann Nucl Med. 2021 Apr;35(4):493-503. doi: 10.1007/s12149-021-01589-5. Epub 2021 Feb 2. Ann Nucl Med. 2021. PMID: 33532992

4

¹⁸F-Boramino acid PET/CT in healthy volunteers and glioma patients.

Li Z, Kong Z, Chen J, Li J, Li N, Yang Z, Wang Y, Liu Z. Li Z, et al. Among authors: wang y. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3113-3121. doi: 10.1007/s00259-021-05212-7. Epub 2021 Feb 15. Eur J Nucl Med Mol Imaging. 2021. PMID: 33590273

5

Larger ¹⁸F-fluoroboronotyrosine (FBY) active volume beyond MRI contrast enhancement in diffuse gliomas than in circumscribed brain tumors.

Kong Z, Li Z, Chen J, Ma W, Wang Y, Yang Z, Liu Z. Kong Z, et al. Among authors: wang y. EJNMMI Res. 2022 Apr 18;12(1):22. doi: 10.1186/s13550-022-00896-w. EJNMMI Res. 2022. PMID: 35435593 Free PMC article.

6

Comprehensive ability evaluation and trend analysis of patients with malignant intracranial tumors in the perisurgery period.

Wang Y, Chen W, Yang T, Zhao B, Zhou L, Kong Z, Wang Y, Dai C, Wang Y, Ma W. Wang Y, et al. Brain Behav. 2021 Nov;11(11):e02192. doi: 10.1002/brb3.2192. Epub 2021 Sep 23. Brain Behav. 2021. PMID: 34554656 Free PMC article.

7

Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.

Yang T, Liu D, Fang S, Ma W, Wang Y. Yang T, et al. Among authors: wang y. J Clin Med. 2022 Sep 4;11(17):5221. doi: 10.3390/jcm11175221. J Clin Med. 2022. PMID: 36079151 Free PMC article. Review.

8

Clinical strategies to manage adult glioblastoma patients without MGMT hypermethylation.

Liu D, Yang T, Ma W, Wang Y. Liu D, et al. Among authors: wang y. J Cancer. 2022 Jan 1;13(1):354-363. doi: 10.7150/jca.63595. eCollection 2022. J Cancer. 2022. PMID: 34976195 Free PMC article. Review.

9

Anti-PD-1 plus anti-VEGF therapy in multiple intracranial metastases of a hypermutated, IDH wild-type glioblastoma.

Guo X, Wang S, Wang Y, Ma W. Guo X, et al. Among authors: wang y, wang s. Neuro Oncol. 2021 Apr 12;23(4):699-701. doi: 10.1093/neuonc/noab005. Neuro Oncol. 2021. PMID: 33556173 Free PMC article. No abstract available.

10

Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.

Shi Y, Kong Z, Liu P, Hou G, Wu J, Ma W, Cheng X, Wang Y. Shi Y, et al. Among authors: wang y. Cells. 2021 May 10;10(5):1142. doi: 10.3390/cells10051142. Cells. 2021. PMID: 34068501 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298,022 results

Search Page

Filters